ETX-636

N/A

Report date: 2026/05/07 20:00:36
NME

Base Information

Drug NameETX-636
Drug Alias NameETX-636
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase alpha inhibitors
TargetsPhosphatidylinositol 3 kinase alpha
Therapy Area/IndicationsSolid tumoursBreast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesEnsem Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEnsem Therapeutics (Shanghai) LtdEnsem TherapeuticsEnsem Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursBreast Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A